Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 68218

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 05, 2014
Product types
Drug
Classifications
Class I
Statuses
Terminated
Recalling firm wording
Eugene Oregon, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.

D-1613-2014
Recall number
D-1613-2014
Initiated
May 05, 2014
Classification
Class I
Status
Terminated
Recalling firm
Eugene Oregon, Inc.
Quantity
136 boxes

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.

Code information

All lots

Distribution pattern

To retailers in MD, TX, FL, PA, IL, NJ, IN, LA, WA, ME, SC

drug · product 2 of 3

MOJO RISEN, 650 mg, 2 capsule per pouch, Distributed by: Mojo Risen, LLC, Springville, UT 84663

D-1614-2014
Recall number
D-1614-2014
Initiated
May 05, 2014
Classification
Class I
Status
Terminated
Recalling firm
Eugene Oregon, Inc.
Quantity
57 boxes

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.

Code information

All lots

Distribution pattern

To retailers in MD, TX, FL, PA, IL, NJ, IN, LA, WA, ME, SC

drug · product 3 of 3

AFRICAN BLACK ANT, 2800 mg, 6 capsules per box, produced by: Qinghan Hongwei Bioengineering Company, No. 158, Renmin Road, Xining City.

D1612-2014
Recall number
D1612-2014
Initiated
May 05, 2014
Classification
Class I
Status
Terminated
Recalling firm
Eugene Oregon, Inc.
Quantity
460 boxes

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.

Code information

All lots

Distribution pattern

To retailers in MD, TX, FL, PA, IL, NJ, IN, LA, WA, ME, SC

Field note

Send feedback

We'll only use this to respond to your feedback.